Company patents
Technische Universiteit Eindhoven
Technische Universiteit Eindhoven's patent strategy reveals a strong, albeit fluctuating, focus on Material & Chemical Analysis, which constitutes 23.8% of its portfolio and saw a significant 150.0% YoY increase in 2025 before a 60.0% decline so far in 2026. While Medical Diagnostics & Surgery shows an emerging focus with a 100.0% YoY growth so far in 2026, the university appears to be shifting away from areas like Non-metallic Inorganic Compounds and Photovoltaic Cells (Legacy CPC), both experiencing 100.0% YoY declines in 2026 and 2025 respectively, after a brief surge in 2024.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
63 US filings (since 2023) · 12 categories · 20 themes
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Self-contained or modular devices designed to automate and integrate multiple steps of molecular diagnostic assays, from sample preparation to result interpretation, often for point-of-care or high-throughput applications.
The design and manufacturing of integrated circuits that combine optical and electronic components, particularly for high-speed data communication between processors and memory.
Technologies and materials for capturing carbon dioxide from gas streams and subsequently converting it into valuable chemical products or materials, rather than simply storing it.
Novel designs and configurations for heat exchangers that improve heat transfer efficiency, compactness, or enable specific phase change or separation processes within refrigeration and heat pump cycles.
Systems and components designed to store thermal energy, often using sensible, latent (phase change material), or thermochemical reactions, for later release and utilization in various applications.
Identification and measurement of specific nucleic acid sequences (DNA, RNA), their expression levels, or epigenetic modifications (e.g., methylation) as indicators for disease presence, progression, risk, or treatment response.
Technologies and systems for removing unwanted components or separating desired gases from a mixed gas stream, including adsorption, absorption, and membrane-based methods.
Methods and reagents designed to improve the specificity, efficiency, or yield of nucleic acid capture, ligation, amplification, or library preparation steps, particularly for sequencing applications or quantitative analysis.
Techniques for driving electrophoretic displays, including managing remnant voltage, optimizing particle movement, and specific addressing pulse schemes to improve optical quality and update speed.
Membrane and depth filtration for industrial separation, gas purification, and bioprocess clarification including cross-flow, dead-end, tangential flow filtration, and oil/water separation.
Enclosed medical systems designed to provide controlled therapeutic environments, such as hyperbaric conditions or purified air for vulnerable patients, often featuring modularity and specialized controls for patient and operator convenience.
Methods and kits for amplifying nucleic acids at a constant temperature, enabling faster results and point-of-care applications, often used for pathogen or contamination detection.
Development of materials with tailored porosity, surface chemistry, or structure, such as metal-organic frameworks (MOFs), zeolites, or superficially porous particles, for selective adsorption, ion exchange, or chromatographic separations.
Mixtures of liquid crystal compounds and other additives, such as monomers or carbon black, designed to achieve specific optical, electrical, or physical properties for use in liquid crystal displays (LCDs) or other electro-optical devices.
Catalytic processes and novel catalyst materials designed to efficiently produce hydrogen gas from various feedstocks, including hydrocarbons (e.g., methane, natural gas) and ammonia.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
Integrated systems and specialized instruments for performing delicate surgical procedures on the eye, often involving the delivery, manipulation, or monitoring of ophthalmic implants.
Implantable devices used for the fixation, fusion, or replacement of bone structures, particularly in the spine and extremities.
Patents
Showing 1-10 of 96